Download PDF
Nuklearmedizin 1978; 17(03): 110-125
DOI: 10.1055/s-0037-1620680
Originalarbeiten – Original Articles
Schattauer GmbH

Time-Dependent Characteristics of Sn-Complexes for Preparing 99mTc-Labelled Radiopharmaceuticals and their Bioavailabilities - a Review

Zeitabhängige Charakteristika komplexer Zinnverbindungen zur Herstellung 99mTc-markierter Radiopharmaka und deren biologische Verfügbarkeit — eine Übersicht
O.P.D Noronha
Further Information

Publication History

Received: 12 October 1977

Publication Date:
09 January 2018 (online)

    Permissions and Reprints

A review is made of some of the factors affecting bioavailability of diagnostic 99mTc-radiopharmaceuticals currently used in the practice of nuclear medicine.

Es wird eine Übersicht über eine Reihe von Faktoren gegeben, die die biologische Verfügbarkeit derzeit in der Nuklearmedizin verwendeter diagnostischer 99mTc-markierter Radiopharmaka beeinflussen.

 

  • References

  • 1 Ackerhalt R. E, Blau M, Bakshi S, Sondel J. A. Comparative study of three 99mTc-labelled phosphorus compounds and 18F-fluoride for skeletal imaging. J. nucl. Med 1974; 15: 1153-1157.
    PubMedGoogle Scholar
  • 2 Ajmani S. K, Lerner S. R, Pircher F. J. Bone scan artifact caused by hyperhidrosis. J. nucl. Med 1977; 18: 801-802.
    PubMedGoogle Scholar
  • 3 Arnold R. W, Subramanian G, McAfee J. G, Blair R. J, Thomas F. D. Comparison of 99mTc complexes for renal imaging. J. nucl. Med 1975; 16: 357-367.
    PubMedGoogle Scholar
  • 4 Arzoumanian A, Rosenthall L, Seto H. Clinical comparison of 99mTc-labelled preformed phytate colloid and sulfur colloid. J. nucl. Med 1977; 18: 118-120.
    PubMedGoogle Scholar
  • 5 Atkins H. L, Cardinale K. G, Eckelman W. C, Hauser W, Klopper J. F, Richards P. Evaluation of 99mTc-DTPA prepared by three different methods. Radiology 1971; 98: 674-677.
    CrossrefPubMedGoogle Scholar
  • 6 Baker R. J, Bellen J. C, Ronai P. M. Technetium-99m-pyridoxylidene glutamate: a new hepatobiliary radiopharmaceutical. I. Experimental aspects. J. nucl. Med 1975; 16: 720-727.
    PubMedGoogle Scholar
  • 7 Bardy A, Fouye H, Gobin R, Bydon J, deTovar G, Panneciere C, Hegesippe M. Technetium-99m labeling by means of stannous pyrophosphate: application to bleomycin and red blood cells. J. nucl. Med 1975; 16: 435-437.
    PubMedGoogle Scholar
  • 8 Bell E. G, McAfee J. G, Subramanian G. Radiopharmaceuticals in pediatrics. In Pediatric Nuclear Medicine. Eds James Jr. A. E., Wagner Jr. H. N., Cooke R. E.. Philadelphia: W. B. Saunders Co; 1974: 84
    Google Scholar
  • 9 Billinghurst M. W. Chromatographic quality control of 99mTc-labelled compounds. J. nucl. Med 1973; 14: 793-797.
    PubMedGoogle Scholar
  • 10 Billinghurst M. W, Palser R. F. Gel chromatography as an analytical tool for 99mTc-radiopharmaceuticals. J. nucl. Med 1974; 15: 722-723.
    PubMedGoogle Scholar
  • 11 Billinghurst M. W, Rampel S. A qualitative method of determining the level of oxidant in a solution of (99mTc) pertechnetate. J. nucl. Med 1977; 18: 744-746.
    PubMedGoogle Scholar
  • 12 Bobinet D. D, Sevrin R, Zurbriggen M. T, Spotter L, Cohen M. B. Lung uptake of 99mTc-sulfur colloid in patients exihibiting presence of Al+3 in plasma. J. nucl. Med 1974; 15: 1220-1222.
    PubMedGoogle Scholar
  • 13 Bowen B. M, Henderson D. N, Kellam J. E, Wood D. E. Technetium99m cysteine - an agent for renal scintigraphy. Amer. J. Hosp. Pharm 1972; 29: 502-505.
    Google Scholar
  • 14 Breslow K, Halpern S. E, Schwartz F. C, Alazraki N. P, Ashburn W. L. Stability studies and tumor uptake of a technetiumtetracycline complex. J. nucl. Med 1974; 15: 987-990.
    PubMedGoogle Scholar
  • 15 Brody K. R, Hosain P, Spencer R. P, Hosain F, Wagner Jr. H. N.. Technetium-99m labelled imidophosphate: an improved bone-scanning radiopharmaceutical. Brit. J. Radiol 1976; 49: 267-269.
    CrossrefPubMedGoogle Scholar
  • 16 Brunn P. Standardized sterile kits for preparation of 99mTc-labelled albumin, macroalbumin, iron ascorbic acid complex and antimony sulphide colloid. Scand. J. clin. Lab. Invest 1971; 28: 313-323.
    CrossrefPubMedGoogle Scholar
  • 17 Brunn P, Lingensmith W. C.. III A comment on the possibility of 99mTc-sulfur colloid retention in the lungs. J. nucl. Med 1974; 15: 726-727.
    PubMedGoogle Scholar
  • 18 Byun H. H, Rodman S. G, Chang K. E. Soft-tissue concentration of 99mTc-phosphates associated with injections of iron dextran complex. J. nucl. Med 1976; 17: 375-376.
    Google Scholar
  • 19 Callery P. S, Faith W. C, Loberg M. D, Fields A. T, Harvey E. B, Cooper M. D. Tissue distribution of technetium-99m and carbon-14 labeled N-(2,6-dimethyl phenyl carba-noylmethyl) iminodiacetic acid. J. med. Chem 1976; 19: 962-964.
    CrossrefPubMedGoogle Scholar
  • 20 Campeau R. J, Gottlieb S, Kallos N. Aortic aneurysms detected by 99mTc-pyrophosphate imaging. J. nucl. Med 1977; 18: 272-273.
    PubMedGoogle Scholar
  • 21 Caride V. J, Taylor W, Cramer J. A, Gottschalk A. Evaluation of liposome - entrapped radioactive tracers as scanning agents. Part. I. Organ distribution of liposome (99mTc-DTPA) in mice. J. nucl. Med 1976; 17: 1067-1072.
    PubMedGoogle Scholar
  • 22 Castronovo Jr. F. D., Callahan R. J. New bone scanning agents 99mTc-labelled-1 -hydroxy-ethylidene-1 - ldisodium phosphonate. J. nucl. Med 1972; 13: 823-827.
    PubMedGoogle Scholar
  • 23 Chandler W. M, Shuck L. D. Effects of tin on pertechne-tate distribution. J. nucl. Med 1975; 16: 690.
    PubMedGoogle Scholar
  • 24 Chaudhuri T. K. Increased hepatic predilection of bone-seeking radiopharmaceuticals in patients with hypercalcemia. Int. J. nucl. Med. Biol 1976; 3: 199-200.
    CrossrefPubMedGoogle Scholar
  • 25 Chaudhuri T. K. The effect of aluminium and pH on the altered body distribution of 99mTc-EHDP. Int. J. nucl. Med. Biol 1976; 3: 37.
    PubMedGoogle Scholar
  • 26 Chaudhuri T. K. Liver uptake of 99mTc-diphosphonate. Radiology 1976; 119: 485-486.
    CrossrefPubMedGoogle Scholar
  • 27 Chaudhuri T. K, Chaudhuri T. K, Gulesserian H. P, Christie J. H. Extraosseous non calcified soft-tissue uptake of 99mTc-polyphosphate. J. nucl. Med 1974; 15: 1054-1056.
    PubMedGoogle Scholar
  • 28 Chervu L. R, Lee H. B, Goyal Q, Blaufox M. D. Use of 99mTc-Cu-DTPA complex as a renal function agent. J. nucl. Med 1977; 18: 62-66.
    PubMedGoogle Scholar
  • 29 Cohen Y. Purity criteria and general specifications of radiopharmaceuticals. In: Analytical Control of Radiopharmaceuticals - Proceedings of a panel. IAEA, Vienna 1970, pp. 1-180.
    Google Scholar
  • 30 Cohen Y, Besnard M. Analytical methods of radiopharmaceutical quality control. In Radiopharmaceuticals. Eds Subramanian G., Rhodes B. A., Cooper J. F, Sodd V. J.. New York: Soc. Nucl. Med. Inc.; 1975: 207-227.
    Google Scholar
  • 31 Coleman R. E. Renal colloid localization. J. nucl. Med 1974; 15: 367-368.
    PubMedGoogle Scholar
  • 32 Colombetti L. G, Moerlien S, Patel G. C, Pinsky S. M. Rapid determination of oxidation state of unbound 99mTc and labelling yield in 99mTc-labelled radiopharmaceuticals. J. nucl. Med 1976; 17: 805-809.
    PubMedGoogle Scholar
  • 33 Colombetti L. G, Moerlien S, Pinsky S. Rapid and reliable preparation of macroaggregated albumin suitable for lung scintigraphy. Int. J. nucl. Med. Biol 1975; 2: 180-184.
    CrossrefPubMedGoogle Scholar
  • 34 Cooper P. A, Zimmer A. M. Radiochemical purity and stability of commercial 99mTc-stannous DTPA kits using a new chromatography technique. J. nucl. Med. Tech 1975; 3: 208-209.
    Google Scholar
  • 35 Counsell R. E, Ice R. D. The design of organ-imaging radiopharmaceuticals. In: Drug Design, Vol. VI. Ed. New York: E. J. Ariens. Academic Press; 1975: 171-259.
    Google Scholar
  • 36 Coupai J. Do colloids cause you problems? A clear solution is’nt in sight. J. nucl. Med 1977; 18: 852-853.
    PubMedGoogle Scholar
  • 37 Davis M. A, Holman B. L, Carmel A. N. Evaluation of radiopharmaceuticals sequestered by acutely damaged myocardium. J. nucl. Med 1976; 17: 911-917.
    PubMedGoogle Scholar
  • 38 Davis M. A, Kaplan M. L, Ahuberg D. S, Cole C. N. A modified Tc-99m phytate colloid for liver-spleen imaging. Int. J. appl. Radiat 1977; 28: 123-130.
    CrossrefPubMedGoogle Scholar
  • 39 DeLigny C. L, Gelsema W. L, Brunis M. H. The influence of experimental conditions on the efficiency of labeling of human serum albumin with 99mTc using Sn(II) as the reductant. Int. J. appl. Radiat 1976; 27: 351-356.
    CrossrefPubMedGoogle Scholar
  • 40 Deutsch E, Elder R. C, Lange B. A, Vaal M. J, Lay D. G. Structural characterization of a bridged 99mTc-Sn-dimethyl-glyoxime complex: Implications for the chemistry of 99mTc-radiopharmaceuticals prepared by the Sn(II) reduction of pertechnetate. Proc. nat. Acad. Sci. (Wash.) 1976; 73: 4287-4289.
    CrossrefPubMedGoogle Scholar
  • 41 Deutsch M. E, Redmond M. L, Mead L. W. Freeze-dried kits for preparing radiopharmaceuticals from 99mTc. In: Radiopharmaceuticals and Labelled Compounds. Proceedings of a Symposium. Vol. 1. IAEA, Vienna: 1973: 189-194.
    Google Scholar
  • 42 Deutsch P, Gunther T, Rohnett M. Dissociation constants of ethane-1-hydroxy-1, 1-diphosphonate (EHDP) and dichloromethylene diphosphonate (C12MDP) for H +, Ca2 +, Mg2+ and Zn2 + . Z. Naturforsch 1976; 31: 661-663.
    CrossrefGoogle Scholar
  • 43 Dewanjee M. K, Fliegel C, Treves S, Davis M. A. 99mTc-tetracyclines: preparation and biological evaluation. J. nucl. Med 1974; 15: 176-182.
    PubMedGoogle Scholar
  • 44 Donaldson J. D, Moser W. Pure tin(II) sulfate. J. chem. Soc 1960; 4000-4003.
    CrossrefGoogle Scholar
  • 45 Dumortier A. G, Jeghers O. M, Decostre Ph, Fallais C. J. Indirect influence of sodium nitrate on the radiochemical purity of a Tc-sulfur colloid. Int. J. appl. Radiat 1974; 25: 189-191.
    CrossrefPubMedGoogle Scholar
  • 46 Dunnick J. K, Kriss J. P. Studies of radiopharmaceutical enclosing lipid-protein vesicles found from native plasma components. J. nucl. Med 1977; 18: 183-186.
    PubMedGoogle Scholar
  • 47 Eckelman W, Meinken G, Richards P. Chemical state of 99mTc in biomedical products. J. nucl. Med 1971; 12: 596-600.
    PubMedGoogle Scholar
  • 48 Eckelman W. C, Reba R. C, Kubota H, Stevenson J. S. 99mTc-pyrophosphate for bone imaging. J. nucl. Med 1974; 15: 279-283.
    PubMedGoogle Scholar
  • 49 Eckelman W. C, Richards P. Instant 99mTc-DTPA. J. nucl. Med 1970; 12: 761.
    Google Scholar
  • 50 Eckelman W. C, Richards P. Analytical pitfalls with 99mTc-labelled compounds. J. nucl. Med 1972; 13: 202-204.
    PubMedGoogle Scholar
  • 51 Elson M. E, Shafer R. B. Quality assurance for 99mTc-Sn-pyrophosphate. J. nucl. Med 1976; 17: 918-923.
    PubMedGoogle Scholar
  • 52 Fischer K. C, Shapiro S, Treves S. Visualization of spleen with a bone-seeking radiopharmaceutical in a child with sickle-cell anemia. Radiology 1977; 122: 398.
    CrossrefPubMedGoogle Scholar
  • 53 Fitzer P. M. 99mTc-polyphosphate concentration in neuroblastoma. J. nucl. Med 1974; 15: 904-906.
    PubMedGoogle Scholar
  • 54 Flesh L. H, Kihm R. H, Ciccio S. S. Radionuclide imaging of aortic involvement in Buerger’s disease. J. nucl. Med 1977; 18: 125-127.
    PubMedGoogle Scholar
  • 55 George E. A, Henry R. E, Donati R. M. Monitoring rejected renal grafts with 99mTc-sulfur colloid (and reply). J. nucl. Med 1976; 17: 939-940.
    Google Scholar
  • 56 Georgen T. K, Alazraki N. P, Halpern S. P, Heath V, Ashburn W. L. “Cold” bone lesions: a newly recognized phenomenon of bone imaging. J. nucl. Med 1974; 15: 1120-1124.
    PubMedGoogle Scholar
  • 57 Gil M. C, Palma T, Radicella R. Electrolytical labeling of 99mTc-radiopharmaceuticals. Int. J. appl. Radiat 1976; 27: 69-72.
    CrossrefPubMedGoogle Scholar
  • 58 Glenn H. J, Kidwell R. E. Radioactive pharmaceuticals and the concept of stability. In: Radioactive Pharmaceuticals. Proceedings of a Symposium. Eds Andrews G. A, Kniseley R. M, Wagner Jr. H. N.. U.S.A.E.C.; Oak Ridge: 1966: 165-175.
    Google Scholar
  • 59 Goy W, Crowe W. J. Splenic accumulation of 99mTc-di-phosphonate in a patient with sickle cell disease. J. nucl. Med 1976; 17: 1108-1109.
    PubMedGoogle Scholar
  • 60 Hagan P. L, Chauncey Jr. D. M., Halpern S. E, Ayres P. R. 99mTc-thiomalic acid complex: A non-stannous chelate for renal scanning. J. nucl. Med 1977; 18: 353-359.
    PubMedGoogle Scholar
  • 61 Hambright P, Adabi A, Reid J, Maitland D. Rapid spot test for stannous tin levels in 99mTc kits. J. nucl. Med. Tech 1977; 5: 88-89.
    Google Scholar
  • 62 Hambright P, McRae J, Valk P. E, Bearden A. J, Shipley B. A. Chemistry of technetium radiopharmaceuticals I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc. J. nucl. Med 1975; 16: 478-482.
    PubMedGoogle Scholar
  • 63 Haney T. A, Ascanio I, Gigliotti J. A, Gusmano E. A, Bruno G. A. Physical and biological properties of a 99mTc-sul-fur colloid preparation containing disodium edetate. J. nucl. Med 1971; 12: 64-68.
    PubMedGoogle Scholar
  • 64 Harper P. V, Lathrop K. A, Gottschalk A. Pharmacodynamics of some technetium-99m preparations. In: Radioactive Pharmaceuticals Proceedings of a Symposium. Eds Andrews G. A, Kniseley R. M, Wagner Jr. H. N.. U.S.A.E.C.; Oak Ridge: 1966: 335-358.
    Google Scholar
  • 65 Hauser W, Atkins H. L, Nelson K. G, Richards P. Technetium-99m DTPA: A new radiopharmaceutical for brain and kidney scanning. Radiology 1970; 94: 679-684.
    CrossrefPubMedGoogle Scholar
  • 66 Hawkins L. A, McAlister J. M. The use of 99mTc antimony sulphide colloid for liver scanning: its preparation and some clinical and experimental observations. Brit. J. Radiol 1969; 42: 657-661.
    CrossrefPubMedGoogle Scholar
  • 67 Heller L, Shafferman A, Davis M. The effecto of gamma irradiation on KTcO4 solutions. In: Israel Atomic Energy Commission - Research Laboratories Annual Report 1975. IA-1321, IAEC, Tel Aviv. 1976: 200
    Google Scholar
  • 68 Higgins C. B, Taketa R. M, Taylor A, Halpern S. E, Ashburn W. L. Renal uptake of 99mTc-sulfur colloid. J. nucl. Med 1974; 15: 564-566.
    PubMedGoogle Scholar
  • 69 Hirsch J. I, Fogel W. M, Fratkin M. J. Locallization of the renal cortical imaging agent 99mTc-Sn-DMSA in the bowel. Radiology 1977; 122: 404.
    CrossrefPubMedGoogle Scholar
  • 70 Hladik III W. B., Study K. T, Gallagher J. H, Rhodes B. A. Quality control of radiochemical purity by a rapid feedback system. J. nucl. Med. Tech 1977; 3: 94-100.
    Google Scholar
  • 71 Hotte C. E, Ice R. D. Thermaland radiolytic decomposition of 131I-19-iodocholesterol. J. nucl. Med 1974; 15: 38-41.
    PubMedGoogle Scholar
  • 72 Hosain F. Quality control of 99mTc-DTPA by double tracer technique. J. nucl. Med 1974; 15: 442-445.
    PubMedGoogle Scholar
  • 73 Hosain P. Technetium-99m labelled pyrophosphate: a simple and reproducible bone scanning agent. Brit. J. Radiol 1973; 46: 724-728.
    CrossrefPubMedGoogle Scholar
  • 74 Hosain P, Hosain F. Significance of femur and liver radioactivity in relation to quality and fate of phosphate complexes with technetium-99m. Nucl.-Med 1976; XV: 95-96.
    Google Scholar
  • 75 Huberty J. P. Long shelf-life of 99mTc-MAA lung particle kits. J. nucl. Med 1974; 15: 464.
    PubMedGoogle Scholar
  • 76 Huberty J. P, Hattner R. S, Powell M. R. A 99mTc-pyro-phosphate kit: a convenient, commercial and high quality skeletal imaging agent. J. nucl. Med 1974; 15: 124-126.
    PubMedGoogle Scholar
  • 77 Hurley P. J. Organ visualization and related studies - clinical value. In: Recent Advances in Clinical Nuclear Medicine-1. Eds.: W. R. Greig, F. C. Gillespie. Churchill Livingstone, London 1975, pp. 59-105.
    Google Scholar
  • 78 Ikeda I, Inoue O, Kurata K. A new preparation method for 99mTc-phytate. J. nucl. Med 1976; 17: 389-393.
    PubMedGoogle Scholar
  • 79 Ikeda I, Inoue O, Kurata K. Chemical and biological studies on 99mTc-DMS. II. Effect of Sn(II) on the formation of various Tc-DMS complexes. Int. J. appl. Radiat 1976; 27: 681-688.
    PubMedGoogle Scholar
  • 80 Ikeda I, Inoue O, Uchida J, Sugisawa Y, Kurata K, Kato S. A simple, rapid and effecient preparation of 99mTd compounds by electrolysis. (IV) 99mTc-tetracycline. Radioisotopes (Tokyo) 1974; 23: 551-556.
    Google Scholar
  • 81 Jeyasingh K, Glass H. I. Preparation of 99mTc-iron ascorbic acid complex for kidney scanning. Int. J. appl. Radiat 1970; 21: 238-239.
    CrossrefPubMedGoogle Scholar
  • 82 Jones A. G, Davis M. A, Dewanjee M. K. 113mIn-labelled bone scanning agents. Radiology 1975; 17: 727-730.
    Google Scholar
  • 83 Kaplan S. A, Jack M. L. Utility of bioavailability studies in drug development. Drug Develop, and ind. Pharmacy 1977; 3: 39-64.
    Google Scholar
  • 84 Kaplan W. D, Holman B. L, Liebow P. A, Davis M. A. Enhanced detection of a skeletal lesion with delayed 99mTc-polyphosphate bone scanning. J. nucl. Med 1974; 15: 47-49.
    PubMedGoogle Scholar
  • 85 Khentigan A, Garrett M, Lum D, Winchell H. S. Effects of prior administration of Sn(II) complexes on in vivo distribution of 99mTc-pertechnetate. J. nucl. Med 1976; 17: 380-384.
    PubMedGoogle Scholar
  • 86 Klingensmith III W. C., Tsan M, Wagner Jr. H. N.. Factors affecting the uptake of 99mTc-sulfur colloid by the lung and kidney. J. nucl. Med 1976; 17: 681-684.
    PubMedGoogle Scholar
  • 87 Krejcarek G. E, Wicks J. H, Heerwald P. E, Tucker K. L, Kubik V.M, Newmark R. A, Williams R. C. The structure of stannous dimercaptosuccinic acid chelates. J. nucl. Med 1976; 17: 565.
    Google Scholar
  • 88 Krishnamurthy G. T, Huebotter R. J, Tubis M, Bland W. H. Pharmaco-kinetics of current skeleton-seeking radiopharmaceuticals Amer. J. Roentgenol 1976; 126: 293-301.
    CrossrefPubMedGoogle Scholar
  • 89 Krishnamurthy G. T, Tubis M, Endow J. S, Singhi V, Walsh C. F, Blahd W. H. Clinical comparison of the kinetics of 99mTc-labelled polyphosphate and diphosphonate. J. nucl. Med 1974; 15: 848-855.
    PubMedGoogle Scholar
  • 90 Kristensen K, Pederson B. Lung retention of 99mTc-sulfur colloid. J. nucl. Med 1975; 16: 439-440.
    PubMedGoogle Scholar
  • 91 Krogsgaard O. W. Radiochemical purity of various 99mrelabelled bone-scanning agents. Eur. J. nucl. Med 1976; 12: 15-17.
    Google Scholar
  • 92 Kubota H, Eckelman W. C, Poulose K. P, Reba R. C. Technetium-99m-pyridoxylidene glutamate, a new agent for gall bladder imaging: comparison with 131I-Rose Bengal. J. nucl. Med 1976; 17: 36-39.
    PubMedGoogle Scholar
  • 93 Kuperus J, Lyons K. P. Chromatography of 99mTc-labelled radiopharmaceuticals. J. nucl. Med 1977; 18: 494-495.
    PubMedGoogle Scholar
  • 94 Larson S. M, Nelp W. B. Radiopharmacology of a simplified technetium-99m-colloid preparation for photoscan-ning. J. nucl. Med 1966; 7: 817-826.
    PubMedGoogle Scholar
  • 95 Lin T. H, Khentigan A, Winchell H. S. A 99mTc-chelate substitute for organoradiomercurial renal agents. J. nucl. Med 1974; 15: 34-35.
    PubMedGoogle Scholar
  • 96 Lin T. H, Khentigan A, Winchell H. S. A 99mTc-labelled replacement for 131I-Rose Bengal in liver and biliary tract studies. J. nucl. Med 1974; 15: 613-615.
    PubMedGoogle Scholar
  • 97 Loberg M. D, Cooper M, Harvey E, Callery P, Faith W. Development of new radiopharmaceuticals based on N-sub-stitution of iminodiacetic acid. J. nucl. Med 1976; 17: 633-638.
    PubMedGoogle Scholar
  • 98 Lyons K. P, Kuperus J, Glenn H. W. Localization of Tc-99m pyrophosphate in the liver due to massive liver necrosis. J. nucl. Med 1977; 18: 550-552.
    PubMedGoogle Scholar
  • 99 Lyster D. M, Scott J. R, Mincey E. K, Morrison R. T. Preparation of a 99mTc-Sn-MAA kit for use in nuclear medicine. J. nucl. Med 1974; 15: 198-199.
    PubMedGoogle Scholar
  • 100 Mazzola A. L, Barker M. H, Belliveau R. E. Accumulation of 99mTc-diphosphonate at sites of intramuscular iron therapy. J. nucl. Med. Tech 1976; 4: 133-135.
    Google Scholar
  • 101 McCormick M. V, Sinclair M. D, Wahner H. W. Chromatographic quality of three 99mTc bone-imaging agents. J. nucl. Med. Tech 1976; 4: 189-192.
    Google Scholar
  • 102 McKusick K. A, Mahmud L. S, Kirchner P. T. An interesting artifact in radionuclide imaging of the kidneys. J. nucl. Med 1973; 14: 113-114.
    PubMedGoogle Scholar
  • 103 McLean J. R, Wise P. Impurities in a 99mTc-lung imaging kit. J. nucl. Med. Tech 1977; 5: 28-31.
    Google Scholar
  • 104 McRae J, Hambright P, Valk P, Bearden A. J. Chemistry of 99mTc-tracers II. In vitro conversion of tagged HEDP and pyrophosphate (bone seekers) into gluconate (renal agent)
    Google Scholar
  • 104 Effects of Ca, Fe(II) on in vivo distribution. J. nucl. Med. 1976; 17: 208-211.
    PubMedGoogle Scholar
  • 105 McRae J, Singer R. M, Shipley B, Hook G. R. Alterations in tissue distribution of 99mTc-pertechnetate in rats given stannous tin. J. nucl. Med 1974; 15: 151-155.
    PubMedGoogle Scholar
  • 106 Merlin L. Use and benefits of kits. In: Radiopharmaceuticals from Generator-Produced Radionuclides. Proceedings of a Panel. IAEA: Vienna; 1971: 145-148.
    Google Scholar
  • 107 Merlin L, Besnard M, Cohen Y. Chimie du Technetium: Influence des systems oxyreducteurs sur la stabilite des complexes utilises come radiopharmaceutiques. In: Radiopharmaceuticals and Labelled Compunds. Proceedings of a Symposium. Vol. I.. IAEA: Vienna; 1973: 63-70.
    Google Scholar
  • 108 Mikhael M. A, Evens R. G. Migration and embolization of macrophages to the lungs - a possible mechanism for colloid uptake in the lung during liver scanning. J. nucl. Med 1975; 16: 22-27.
    PubMedGoogle Scholar
  • 109 Monroe L. A, Thompson W. L, Anderton N. S, Burdine J. A. Evaluation of an improved 99mTc-Sn-aggregated albumin preparation for lung imaging. J. nucl. Med 1974; 15: 192-194.
    PubMedGoogle Scholar
  • 110 Narashiman D. V. S, Mani R. S. Electrolytic preparation of 99mTc-human serum albumin using tin electrodes. Radio-chem. Radioanal. Lett 1975; 20: 307-316.
    Google Scholar
  • 111 Nelson M. F, Melton R. E, Van Wazer J. R. Sodium trimeta phosphate as a bone-imaging agent. I. Animal Studies. J. nucl. Med 1975; 16: 1043-1048.
    PubMedGoogle Scholar
  • 112 Nolan N. G. Intense uptake of 99mTc-diphosphonate by an extraosseous neurofibroma. J. nucl. Med 1974; 15: 1207-1208.
    PubMedGoogle Scholar
  • 113 Noronha O. P. D, Sewatkar A. B, Ganatra R. D. Factors affecting the preparation of 99mTc-sulfur solloid. Eur. J. nucl. Med 1978; 3: 47-54.
    PubMedGoogle Scholar
  • 114 Noronha O. P. D, Sewatkar A. B, Ganatra R. D, Glenn H. J. An alternate approach to the preparation of 99mTc-sulfur colloid. Int. J. nucl. Med. Biol 1975; 2: 184-185.
    CrossrefPubMedGoogle Scholar
  • 115 Noronha O. P. D, Sewatkar A. B, Ganatra R. D, Subramanian G. 99mTc-pyridoxylidene glutamate - a radiopharmaceutical for the hepatobiliary system. Nucl.-Med 1976; XV: 71-74.
    Google Scholar
  • 116 Noronha O. P. D, Sewatkar A. B, Ganatra R. D, Subramanian G. The transport, hepatobiliary distribution and clearance of 99mTc-Sn-lidocaine iminodiacetic acid, 99mTc-Sn-LIDA. Int. J. nucl. Med. Biol 1977; 4: 122-128.
    CrossrefPubMedGoogle Scholar
  • 117 Owunwanne A, Church L. B, Blau M. Effect of oxygen on the reduction of pertechnetate by stannous ion. J. nucl. Med 1977; 18: 822-826.
    PubMedGoogle Scholar
  • 118 Owunwanne A, Weber D. A, O’Mara R. E. Radiochemical analysis of radiopharmaceuticals. The technetium-99m phosphorus compounds. J. nucl. Med 1977; 18: 637.
    Google Scholar
  • 119 Panek K, Dienstbier Z, Raban P. Radioactive pharmaceuticals used in diagnostics. In: Radionuclides in Pharmacology, Vol. II (IEPT). Eds Cohen Y.. Pergamon Press; Oxford: 1971: 753-843.
    Google Scholar
  • 120 Pauwels E. K. J, Feitsma R. I. J. Radiochemical quality control of 99mTc-labelled radiopharmaceuticals. Eur. J. nucl. Med 1977; 2: 97-103.
    PubMedGoogle Scholar
  • 121 Pavel D. G, Zimmer A. M, Patterson V. N. In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization. J. nucl. Med 1977; 18: 305-308.
    PubMedGoogle Scholar
  • 122 Platthy A, Shah U. False positive scintigrams due to malposition of liver. J. nucl. Med 1974; 15: 717-719.
    PubMedGoogle Scholar
  • 123 Porter W. C, Dworkin H. J, Gutkowski R. F. The effect of carrier technetium in the preparation of 99mTc-human serum albumin. J. nucl. Med 1976; 17: 704-706.
    PubMedGoogle Scholar
  • 124 Potsaid M. S, Guiberteau M. J, McKusick K. A. Quality of bone scans compared with time between dose and scan. J. nucl. Med 1977; 18: 787-789.
    PubMedGoogle Scholar
  • 125 Robbings P. J, Fortman D. L, Lewis J. T. A new lung scanning agent: 99mTc(Sn)MAA. Int. J. appl. Radiat 1973; 24: 48183.
    Google Scholar
  • 126 Robinson Jr. G. D., Battaglia D. J. Technetium-99m-te- tracycline: preparation, biological dynamics and uptake in damaged and normal skeletal muscle. Int. J. appl. Radiat 1975; 26: 147-152.
    CrossrefPubMedGoogle Scholar
  • 127 Rollo F. D, Cavalieri R. R, Born M, Blei L, Chew M. Comparative evaluation of 99mTcGH, 99mTcO4 and 99mTcDTPA as brain imaging agents. Radiology 1977; 123: 379-383.
    CrossrefPubMedGoogle Scholar
  • 128 Schümichen C, Nakken K. F. A comparison of the bone seeking properties of short-chained 99mTc-Sn-polyphospha-tes. Nucl.-Med 1974; XIII: 139-143.
    Google Scholar
  • 129 Schümichen C, Rorvick-Schümichen K, Hoffman G. 99mTc-Sn-pyrophosphate complexes, an investigation of its possible structures. Nucl.-Med 1974; XIII: 252-257.
    Google Scholar
  • 130 Sewatkar A. B, Noronha O. P. D, Ganatra R. D. On the stability of a Sn-phytate complex. Nucl.-Med 1975; XIV: 293-297.
    Google Scholar
  • 131 Sewatkar A. B, Noronha O. P. D, Ganatra R. D, Glenn H. J. Some aspects of the radiopharmaceutics of 99mTc- phytate. Nucl.-Med 1975; XIV: 46-51.
    Google Scholar
  • 132 Sewatkar A. B, Subramanian G, McAfee J. G, Rosenstreich M, Henderson R. W. A new solid phase reduction system using insoluble stannous salts for the preparation of 99mTc labeled radiopharmaceuticals. Presented at 15th International Annual Meeting of the Society of Nuclear Medicine. Gronigen; Netherlands: Sept 1977: 13-16.
    Google Scholar
  • 133 Silberstein E. B. Calcium, phosphorus and 99mTc “uptake”. J. nucl. Med 1974; 15: 918.
    PubMedGoogle Scholar
  • 134 Skelly J. P. Bioavailability and bioequivalence. J. clin. Pharmacol 1976; 16: 539-545.
    CrossrefPubMedGoogle Scholar
  • 135 Smith T. D, Richards P. A simple kit for the preparation of 99mTc-labelled red blood cells. J. nucl. Med 1976; 17: 126-132.
    PubMedGoogle Scholar
  • 136 Stebner F. C. Steroid effect on the brain scan in a patient with cerebral metastases. J. nucl. Med 1975; 16: 320-325.
    PubMedGoogle Scholar
  • 137 Steigman J, Richards R. Chemistry of technetium-99m. Sem. Nucl. Med 1974; 4: 269-279.
    Google Scholar
  • 138 Stelmach H. A, Quinn J. L.. III Radiopharmaceutical quality control. Sem. Nucl. Med 1974; 4: 295-303.
    Google Scholar
  • 139 Steinman S. Reply to “Impurities in a 99mTc-lung imaging kit”. J. nucl. Med. Tech 1977; 5: 55-56.
    Google Scholar
  • 140 Stern H. S, McAfee J. G, Subramanian G. Preparation, distribution and utilization of technetium-99m-sulfur colloid. J. nucl. Med 1966; 7: 665-675.
    PubMedGoogle Scholar
  • 141 Srivastava S. C, Meinken G, Smith T. D, Richards P. Problems associated with stannous 99mTc-radiopharmaceu-ticals. Int. J. appl. Radiat 1977; 28: 83-95.
    CrossrefPubMedGoogle Scholar
  • 142 Subramanian G, Chander J, Singh M. V, Dham D. N, Lakshmipathi N, Singh B. A new radiopharmaceutical for gall bladder studies. Nucl.-Med 1977; XVI: 83-85.
    Google Scholar
  • 143 Subramanian G, McAfee J. G, Bell E. G, Blair R. J, O’Mara R. E, Ralston P. H. 99mTc-labelled polyphosphate as a skeletal imaging agent. Radiology 1972; 102: 701-704.
    CrossrefPubMedGoogle Scholar
  • 144 Subraminian G, McAfee J. G, Blair R. J, Mehter A, Connor T. 99mTc-EHDP: A potential radiopharmaceutical for skeletal imaging. J. nucl. Med 1972; 13: 947-950.
    PubMedGoogle Scholar
  • 145 Subramanian G, McAfee J. G, Blair R. J, Rosen-streich M, Coco M, Duxbury C. E. Technetium-99m labelled stannous imidophosphate, a new radiodiagnostic agent for bone scanning: Comparison with other complexes. J. nucl. Med 1975; 16: 1137-1143.
    PubMedGoogle Scholar
  • 146 Subramanian G, McAfee J. G, Blair R. J, Thomas F. D. Radiopharmaceuticals for bone and bone-marrow imaging - a review. In: Medical Radionuclide Imaging Vol. II. Proceedings of a Symposium. IAEA; Vienna: 1977: 83-104.
    Google Scholar
  • 147 Subramanian G, McAfee J. G, Henderson R, Rosen-streich M. New bifunctional chelates for designing Tc-99m labelled radiopharmaceuticals. In: Proceedings of First Asia and Oceania Congress of Nuclear Medicine. Sydney; Australia: 1976: 144-149.
    Google Scholar
  • 148 Subramanian G, McAfee J. G, Emhter A, Blair R. J, Thomas F. D. 99mTc-stannous phytate: a new in-vivo colloid for imaging the reticuloendothelial system. J. nucl. Med 1973; 14: 459.
    Google Scholar
  • 149 Sy W. M, Westring D. W, Weinberger G. “Cold” lesions on bone imaging. J. nucl. Med 1975; 16: 1013-1016.
    PubMedGoogle Scholar
  • 150 Taplin G. V. The scintillation scan. In: Clinical Scintillation Scanning. Eds Freeman L. H, Johnson P. M.. Harper & Row; New York: 1969: 119
    Google Scholar
  • 151 Tofe A. J, Francis M. D. Optimization of the ratio of stannous tin: ethane-l-hydroxy-1, 1-diphosphonate for bone scanning with 99mTc-pertechnetate. J. nucl. Med 1974; 15: 69-74.
    PubMedGoogle Scholar
  • 152 Tofe A. J, Francis M. D. In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid. J. nucl. Med 1976; 17: 820-825.
    PubMedGoogle Scholar
  • 153 Trumper Y, Weininger J, Lubin E. 99mTc-pyridoxylidene glutamate kit: A rapid cholescintigraphic agent. Int. J. nucl. Med. Biol 1976; 3: 45-48.
    CrossrefPubMedGoogle Scholar
  • 154 Valk P. E, Dilts C. A, McRae J. A possible artifact in gel chromatography of some 99mTc-chelates. J. nucl. Med 1973; 14: 235-237.
    PubMedGoogle Scholar
  • 155 Vanlic-Razumenic N. M, Gorkic D. A. Studies of chemical and biological properties of 99mTc-DMS (dimercaptosuc-cinic acid) - renal imaging agent. Eur. J. nucl. Med 1976; 1: 235-242.
    CrossrefPubMedGoogle Scholar
  • 156 Vieras F, Boyd C. M. Diagnostic value of renal imaging incidental to bone scintigraphy with 99mTc-phosphate compounds. J. nucl. Med 1975; 16: 1109-1114.
    PubMedGoogle Scholar
  • 157 Wagner Jr. H. N.. The search of magic bullets. In: Radiopharmaceuticals Eds Subramanian G, Rhodes B. A, Cooper J. F, Sodd V. J.. Soc. Nucl Med. Inc.; New York: 1975: XIII-XV.
    Google Scholar
  • 158 Wagner Jr. H. N.. et al. The lung and The gastrointestinal tract, liver and pancreas. In: Principles of Nuclear Medicine Ed. Wagner Jr. H. N.. Philadelphia: W. B. Saunders Co.,; 1969: 472-530. And 548-627
    Google Scholar
  • 159 Waxman A. D, Tanaceseu D, Siemsen J. K, Wolf-stein R. S. Technetium-99m glucoheptonate as a brain-scanning agent: Critical comparison with pertechnetate. J. nucl. Med 1976; 17: 345-348.
    PubMedGoogle Scholar
  • 160 Webber M. M. Affinity of fibrin deposits for Tc-sulfur colloid. J. nucl. Med 1976; 17: 940.
    PubMedGoogle Scholar
  • 161 Weiss S, Conway J. J. Bone imaging artifacts. J. nucl. Med. Tech 1977; 5: 17-22.
    Google Scholar
  • 162 Winchell H. S. Effect of tin-reduced enzymes on pertech-netate distribution, J. nucl. Med 1976; 17: 941-942.
    Google Scholar
  • 163 Winston M. A, Halpern S. E, Weiss E. R, Endow J. S, Blahd W. H. A critical evaluation of 99mTc-Fe-ascorbic acid complex as a renal scanning agent. J. nucl. Med 1971; 12: 171-175.
    PubMedGoogle Scholar
  • 164 Winter P. F, Perl L. J, Johnson P. M. Lung uptake of colloid during liver-spleen scanning: a normal finding in children. Nucl.-Med 1976; XV: 294-296.
    Google Scholar
  • 165 Yakoyama A, Saji H, Tanaka H, Odori T, Morita R, Mori T, Torizuka K. Preparation of a chemically characterized 99mTc-penicillamine complex. J. nucl. Med 1976; 17: 810-815.
    PubMedGoogle Scholar
  • 166 Yano Y. Radionuclide generators: Current and future applications in nuclear medicine. In: Radiopharmaceuticals. Eds. Subramanian G, Rhodes B. A, Cooper J. F, Sodd V. J.. Soc. Nucl. Med. Inc; New York: 1975: 236-245.
    Google Scholar
  • 167 Yano Y, Anger H. O, McRae J, Honbo D. Lung scanning with technetium-99m ferric hydroxide macroag-gregates. In: Radiopharmaceuticals from Generator-Produced Radionuclides. Proceedings of a Panel. I.A.E.A.; Vienna: 1971: 59-65.
    Google Scholar
  • 168 Yano Y, Chu P, Anger H. O. Tin-117m: production, chemistry and evaluation as a bone scanning agent. Int. J. appl. Radiat 1973; 24: 319-325.
    CrossrefPubMedGoogle Scholar
  • 169 Ziessman H. A. Lung uptake of 99mTc-sulfur colloid in falciparum malaria. J. nucl. Med 1976; 17: 794-796.
    PubMedGoogle Scholar
  • 170 Zimmer A. M, Holmes R. A. A precise chromatographic system for specific technetium-99m radiopharmaceuticals. Nucl.-Med 1975; XV: 192-195.
    Google Scholar
  • 171 Zimmer A. M, Isitman A. T, Holmes R. A. Enzymatic inhibition of diphosponate: dis-phosphonate: A proposed mechanism of tissue uptake. J. nucl. Med 1975; 16: 352-356.
    PubMedGoogle Scholar
  • 172 Zimmer A. M, Pavel D. G. Radiochemical evaluation and image correlation of stabilized and non stabilized 99mTc-Sn disphosphonate kits. J. nucl. Med. Tech 1977; 5: 54-55.
    Google Scholar